SAM-AMP lyases in type III CRISPR defence
Nucleic Acids Research · 2025
DOI: 10.1093/nar/gkaf655 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Haotian Chi und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Biology, University of St Andrews, St Andrews, Fife KY16 9ST, United Kingdom. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Bacterial Proteins, Lyases. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council, European Research Council Advanced Grant, University of St Andrews.
Abstract (Originalsprache)
Type III CRISPR systems detect non-self RNA and activate the enzymatic Cas10 subunit, which generates nucleotide second messengers for activation of ancillary effectors. Although most signal via cyclic oligoadenylate, an alternative class of signalling molecule SAM-AMP, formed by conjugating ATP and S-adenosylmethionine, was described recently. SAM-AMP activates a trans-membrane effector of the CorA magnesium transporter family to provide anti-phage defence. Intriguingly, immunity also requires SAM-AMP degradation by means of a specialized CRISPR-encoded NrN family phosphodiesterase in Bacteroides fragilis. In Clostridium botulinum, the nrn gene is replaced by a gene encoding a SAM-AMP lyase. Here, we investigate the structure and activity of C. botulinum SAM-AMP lyase, which can substitute for the nrn gene to provide CorA-mediated immunity in Escherichia coli. The structure of SAM-AMP lyase bound to its reaction product 5′-methylthioadenosine-AMP reveals key details of substrate binding and turnover by this PII superfamily protein. Bioinformatic analysis revealed a phage-encoded SAM-AMP lyase that degrades SAM-AMP efficiently in vitro, consistent with an anti-CRISPR function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Biology, University of St Andrews, St Andrews, Fife KY16 9ST, United Kingdom.
ORCID-Profile: Tracey M Gloster, Malcolm F White
Förderung
- Biotechnology and Biological Sciences Research Council
- European Research Council Advanced Grant
- University of St Andrews
Zitieren
APA
Chi, H., McMahon, S., Daniel-Pedersen, L., Graham, S., Gloster, T. M., & White, M. F. (2025). SAM-AMP lyases in type III CRISPR defence. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf655
Vancouver
Chi H, McMahon S, Daniel-Pedersen L, Graham S, Gloster TM, White MF. SAM-AMP lyases in type III CRISPR defence. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf655
BibTeX
@article{Chi2025,
author = {Chi, Haotian and McMahon, Stephen and Daniel-Pedersen, Lukas and Graham, Shirley and Gloster, Tracey M and White, Malcolm F},
title = {SAM-AMP lyases in type III CRISPR defence},
journal = {Nucleic Acids Research},
year = {2025},
doi = {10.1093/nar/gkaf655}
}
EUVIMED